Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 171 for “"IFN- β"”.

  1. Characterization of the immunoregulatory roles of IFN-β in T cells and dendritic cells

    … the central nervous system (CNS). Interferon (IFN)-β was the first approved therapy for relapsing-remitting MS more than 20 years ago, however, its mechanism of action remains ill-defined. Using a myelin oligodendrocyte glycoprotein (MOG)-induced murine experimental autoimmune encephalomyelitis …

    toronto-retro Repository record for Characterization of the immunoregulatory roles of IFN-β in T cells and dendritic cells (opens in a new tab)

  2. The Role of STAT1 in Chlamydia-Induced Type I Interferon Responses in Oviduct Epithelium

    … of the oviduct epithelial cells (OEs) secrete IFN-β in a TLR3 dependent manner. However, we showed that the C. muridarum infected TLR3-deficient OEs were still able to secrete minimal amounts of IFN-β into the supernatants, which is suggestive that there are other signaling pathways that …

    iupui Repository record for The Role of STAT1 in Chlamydia-Induced Type I Interferon Responses in Oviduct Epithelium (opens in a new tab)

  3. Μελέτη της δυναμικής μεταγραφικών συμπλόκων in vivo

    … the transcription of the interferon beta (IFN-β) gene, through the coordinate activation of three distinct groups of transcription factors (NF-kB, ATF-2/c-JUN, IRFs). The latter bind to the enhancer of the IFN-β gene in a cooperative manner and they create, in combination with the …

    greece Repository record for Μελέτη της δυναμικής μεταγραφικών συμπλόκων in vivo (opens in a new tab)

  4. Interferon-β moduliert die Expression von Toll-like Rezeptoren in mononukleären Blutzellen und induziert Toll-like Rezeptor 7 in plasmazytoiden dendritischen Zellen von Patienten mit Multipler Sklerose

    … MS-Therapeutikum zugelassene Interferon-β (IFN-β) ist bis heute das am meisten verschriebene3. Es interferiert mit der Virusreplikation, reguliert zahlreiche Gene und moduliert das Immunsystem. Über welchen genauen Mechanismus IFN-β bei Patienten mit MS therapeutisch wirkt, wurde bisher …

    fu-berlin Repository record for Interferon-β moduliert die Expression von Toll-like Rezeptoren in mononukleären Blutzellen und induziert Toll-like Rezeptor 7 in plasmazytoiden dendritischen Zellen von Patienten mit Multipler Sklerose (opens in a new tab)

  5. The clinical and pharmacogenomic determinants of interferon beta induced liver injury in multiple sclerosis

    … withdrawal from the market. Interferon-beta (IFN-β) is a commonly used disease-modifying drug for multiple sclerosis (MS) and is generally safe. However, 30-60% of IFN-β exposed patients experience liver aminotransferase elevations, with an unknown proportion experiencing more severe, …

    ubc Repository record for The clinical and pharmacogenomic determinants of interferon beta induced liver injury in multiple sclerosis (opens in a new tab) Download PDF for The clinical and pharmacogenomic determinants of interferon beta induced liver injury in multiple sclerosis (opens in a new tab)

  6. Η κινητική των εξουδετερωτικών αντισωμάτων έναντι της ιντερφερόνης-β σε ασθενείς με πολλαπλή σκλήρυνση, κατά τη διάρκεια των υποτροπών της νόσου

    … disability. The advent of interferon beta (IFN-ß) in the treatment of relapsing-remitting MS (RRMS) changed the course of the disease by reducing the activity of the disease which is reflected by the amelioration of clinical and radiological parameters. IFN-β preparations possess immunogenic …

    greece Repository record for Η κινητική των εξουδετερωτικών αντισωμάτων έναντι της ιντερφερόνης-β σε ασθενείς με πολλαπλή σκλήρυνση, κατά τη διάρκεια των υποτροπών της νόσου (opens in a new tab)

  7. The effect of LSD1 and HDAC1-2 on osteoclast differentiation.

    … osteoclasts due to increase in interferon-β (IFN-β) genes. LSD1 has been previously shown to interact with histone deacetylase complexes (HDACs). We hypothesized that LSD1 and HDAC1 and HDAC2 work together to regulate IFN-β regulated genes in osteoclasts. To test this hypothesis gene …

    umn Repository record for The effect of LSD1 and HDAC1-2 on osteoclast differentiation. (opens in a new tab)

  8. Role of interferon-α and interferon-β in glomerular injury and repair

    … Effekte viraler Nukleinsäursen, wie auch IFN -α und IFN-β, während Virusinfektionen eine wichtige Rolle spielen, ist wenig über ihre Funktion bei viraler Glomerulonephritis, wie beispielsweise HIV Nephropathie, bekannt. Virusinfektionen aktivieren, vor allem mittels IFN-α und IFN-β …

    lmu-germany Repository record for Role of interferon-α and interferon-β in glomerular injury and repair (opens in a new tab)

  9. Characterization of the anti-inflammatory effects of the Molluscum Contagiosum MC159 protein

    … Factor-α (TNF-α) and anti-viral interferon- β (IFN-β) cytokines are highly expressed in MCV lesions and surrounding tissue. Despite the expression of pro-inflammatory factors, MCV infections cause little inflammation. Not surprisingly, MCV encodes immunomodulatory proteins such as the MC159 …

    uiuc Repository record for Characterization of the anti-inflammatory effects of the Molluscum Contagiosum MC159 protein (opens in a new tab)

  10. The role of the interaction of the influenza B virus NS1 protein with the cellular Brd2 protein

    … thirds of the protein, suppresses interferon-β (IFN-β) synthesis in virus-infected cells by unknown mechanism(s). The induced IFN-β mediates innate immunity. To elucidate the mechanism by which the NS1B effector domain suppresses the production of IFN-β, we identified cellular proteins that …

    texas Repository record for The role of the interaction of the influenza B virus NS1 protein with the cellular Brd2 protein (opens in a new tab)

  11. Mechanism Of Interferon-Beta-Mediated Inhibition Of Il-8 Gene Expression

    … of diseases, including cancer. Interferon-β (IFN-β), a Type I interferon, inhibits the expression of IL-8, but the details of this effect are not known. In this study we investigate transcriptional control of the IL- 8 gene and the mechanism by which IFN-β exerts inhibitory effects on IL-8. …

    uab Repository record for Mechanism Of Interferon-Beta-Mediated Inhibition Of Il-8 Gene Expression (opens in a new tab)

  12. Μελέτη μηχανισμών μεταγραφικής ρύθμισης από τον υποδοχέα CD40

    … mechanisms of two separate pathways leading to IFN-β or TPL2 induction downstream of the CD40/NF-κB/IRF1 axis. IFN-β and the CD40L (CD154) share important roles in the antiviral and antitumor immune responses which led us to the hypothesis that IFN-β could be a physiological target of CD40 …

    greece Repository record for Μελέτη μηχανισμών μεταγραφικής ρύθμισης από τον υποδοχέα CD40 (opens in a new tab)

  13. BV-2 미세아교세포에서 PGE2 에 의한 LPS 유도 IFN-β생성 조절

    … 면역반응과 염증반응을 유발하는 것으로 알려져 있다. 면역 반응 시 생성이 증가되는IFN-β 는 항 바이러스성 물질로 잘 알려져 있으며 최근에는 다발성경화증 (multiple sclerosis) 과 같은 염증성질환의 치료제로 사용되고 있다. 일련의 보고에서 대표적인 proinflammatory mediator 로 잘 알려진 PGE2 가 IFN-β 의 생성을 억제하는 작용이 있는 것으로 보고된 바가 있지만 그 작용 기전에 대해서는 아직 정확히 밝혀진 바가 없다. 본 연구는 PGE2 에 의한 LPS 유도 IFN-β생성 …

    ajou Repository record for BV-2 미세아교세포에서 PGE2 에 의한 LPS 유도 IFN-β생성 조절 (opens in a new tab) Embargoed until 9999-12-31

  14. Bovine herpesvirus type 1 (BHV-1) regulates the innate immune system to promote productive infection and latency

    … expression of the three bovine interferon beta (IFN-β) genes in response to viral infection and virus induced transcription factors in several cell types. These studies demonstrated that BHV-1 infection suppresses the IFN-β response in low passage bovine cells. Two BHV-1-encoded genes: bovine …

    nebraska Repository record for Bovine herpesvirus type 1 (BHV-1) regulates the innate immune system to promote productive infection and latency (opens in a new tab)

  15. Pharmacogenomics of interferon-beta treatment in caucasian multiple sclerosis patients

    … drugs (DMD), including interferon-beta (IFN-β), are administered to reduce the number of relapses and slow disease progression. While IFN-β is a safe and effective MS therapy, up to 50% of patients do not respond adequately to treatment. Determination of response status requires clinical …

    adelaide Repository record for Pharmacogenomics of interferon-beta treatment in caucasian multiple sclerosis patients (opens in a new tab)

Page 1 of 9